A Study To Comapre the Effects of Two Ayurvedic Medicine, Srikhandasava And Patolakaturohinyadi Kashaya, In adults with Alcoholic Fatty Liver Grade II for improving Liver health and Reducing Liver Fat.

A Randomized, Controlled, Open-Label, Clinical Study To Evaluate The Efficacy Of Srikhandasava And Patolakaturohinyadi Kashaya In The Management Of Alcoholic Fatty Liver Grade II - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/097833

Enrollment

200

Registered

2025-11-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K700- Alcoholic fatty liver

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients between 21-50 years age 2. Patients with history of Alcoholic Fatty Liver Grade II 3. Patients with no known systemic disorders 4. Patients irrespective of sex, religion, socioeconomic status will be included. 5. Patients who are not under medication for any condition including ALDs 6. Patient with AUDIT score 16 and above. 7. In case of withdrawal of any participant new patient who fits to the above mentioned inclusion criteria will be included in the study for the completeness and accuracy of the data.

Exclusion criteria

Exclusion criteria: 1. Patients below 21 years of age and above 50 years of age 2. Patients suffering from other systemic disease that interfere with the prognosis and treatment of disease. 3. Patients suffering from any sort of fatal diseases. 4. Patients with the History of more than 5 years. 5. Patients with Non-alcoholic Fatty Liver (NAFLD). 6. Patients with Alcoholic Fatty Liver Grade I, Alcoholic Fatty Liver Grade III, Alcoholic Hepatitis, Cirrhosis, Liver Failure and any other liver diseases which is not caused by Alcoholic Fatty Liver Grade II. 7. The patients who are already under treatment for AFLD/NAFLD or were under the treatment for the above said conditions from any medical system till minimum two weeks prior to the conduct of the study.

Design outcomes

Primary

Measure	Time frame
The primary outcome of the study is the reduction in liver fat content and improvement in liver function in patients with Alcoholic Fatty Liver Grade II.Timepoint: 6 Months	—

Secondary

Measure	Time frame
The secondary outcome focuses on the alleviation of symptoms and improvement in the quality of life of patients.Timepoint: 6 Months	—

Countries

India

Contacts

Public ContactDr Sunil Kumar

Institute for Ayurved Studies and Research (Faculty of Ayurved)

drbs_tomar@yahoo.co.in8950264121

Outcome results